Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Drug Administration Schedule »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Administration Routes < Drug Administration Schedule < Drug Carriers  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 152.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000088 (1999) W. Ondo [États-Unis] ; C. Hunter ; M. Almaguer ; Joseph Jankovic [États-Unis]A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease.
000149 (1999) Yves Agid [France] ; E. Ahlskog ; A. Albanese ; D. Calne ; T. Chase ; J. De Yebenes ; S. Factor ; S. Fahn ; O. Gershanik ; C. Goetz ; W. Koller ; M. Kurth ; A. Lang ; A. Lees ; P. Lewitt ; D. Marsden ; E. Melamed ; P P Michel ; Y. Mizuno ; J. Obeso ; W. Oertel ; W. Olanow ; Werner Poewe [Autriche] ; P. Pollak ; E. TolosaLevodopa in the treatment of Parkinson's disease: a consensus meeting.
000153 (1999) J E Ahlskog [États-Unis] ; R J Uitti ; M K O'Connor ; D M Maraganore ; J Y Matsumoto ; K F Stark ; M F Turk ; O L BurnettThe effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
000200 (2000) L M Shulman [États-Unis] ; A. Minagar ; W J WeinerThe effect of pregnancy in Parkinson's disease.
000208 (2000) H. Apaydin [Turquie] ; S. Ertan ; S. OzekmekçiBroad bean (Vicia faba)--a natural source of L-dopa--prolongs "on" periods in patients with Parkinson's disease who have "on-off" fluctuations.
000235 (2000) V G Evidente [États-Unis] ; C H Adler ; J N Caviness ; J G Hentz ; K. Gwinn-HardyAmantadine is beneficial in restless legs syndrome.
000249 (2000) J L MontastrucTreatment of Parkinson's disease should begin with a dopamine agonist.
000286 (2000) H H Fernandez [États-Unis] ; M C Lannon ; J H Friedman ; B P AbbottClozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
000401 (2000) P J Van Wattum [États-Unis] ; P B Chappell ; D. Zelterman ; L D Scahill ; J F LeckmanPatterns of response to acute naloxone infusion in Tourette's syndrome.
000460 (2001) A. Albanese [Italie] ; U. Bonuccelli ; C. Brefel ; K R Chaudhuri ; C. Colosimo ; T. Eichhorn ; E. Melamed ; P. Pollak ; T. Van Laar ; M. ZappiaConsensus statement on the role of acute dopaminergic challenge in Parkinson's disease.
000461 (2001) G M Petzinger [États-Unis] ; M. Quik ; E. Ivashina ; M W Jakowec ; M. Jakubiak ; D. Di Monte ; J W LangstonReliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate.
000561 (2001) H C Wang [Taïwan] ; Y. HsiehTreatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy.
000670 (2002) Dirk Dressler [Royaume-Uni] ; Hans BigalkeBotulinum toxin antibody type A titres after cessation of botulinum toxin therapy.
000674 (2002) Petr Kanovsk [République tchèque] ; Dagmar Kubová ; Martin Bares ; Hana Hortová ; Hana Streitová ; Ivan Rektor ; Vladimír ZnojilLevodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up.
000730 (2002) Rebecka Klintenberg [Suède] ; Lars Gunne ; Per E. AndrénTardive dyskinesia model in the common marmoset.
000734 (2002) Padraig O'Suilleabhain [États-Unis] ; Richard B. DeweyRandomized trial comparing primidone initiation schedules for treating essential tremor.
000737 (2002) Manavdeep Grewal [Canada] ; Raed Hawa ; Colin ShapiroTreatment of periodic limb movements in sleep with selegiline HCl.
000826 (2002) Sujana Reddy [États-Unis] ; Stewart A. Factor ; Eric S. Molho ; Paul J. FeustelThe effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
000887 (2002) Lance A. Smith [Royaume-Uni] ; Banu C. Tel ; Michael J. Jackson ; Matthew J. Hansard ; Rogelio Braceras ; Céline Bonhomme ; Claire Chezaubernard ; Susanna Del Signore ; Sarah Rose ; Peter JennerRepeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation.
000934 (2002) Alice J. Manson [Royaume-Uni] ; Kirsten Turner ; Andrew J. LeesApomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
000986 (2003) Silvia Folgar [Argentine] ; Emilia Mabel Gatto ; Gabriela Raina ; Federico MicheliParkinsonism as a manifestation of multiple sclerosis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Drug Administration Schedule" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Drug Administration Schedule" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Drug Administration Schedule
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024